Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms
Summary: Controlled release technologies have long been utilized as a method to enhance drug delivery and to maximize drug efficiency. API physicochemical and biopharmaceutic properties play a role in determining if the molecule is suitable for controlled release dosage forms. In this webinar, experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications and predict the effects of release rate on in vitro performance. In addition, the experts will cover all aspects of oral controlled release technologies and discuss current strategies to select the optimal technology to meet the intended release profile.